Determining the directions for developing a methodology for comprehensive assessment of ESG activity in China’s biopharmaceutical territorial-sectoral complexes. (2025). Modern Economics: Problems and Solutions, 12, 61-74. https://doi.org/10.17308/meps/2078-9017/2025/12/61-74